JNJ Buy for bounce over $162JNJ is oversold here and near long term support, I'd expect a bounce over $162 in coming days
JNJ trade ideas
JNJ new bottom?The Algo's have spoken! RSI, MACD, OBV, all indicate a bottom in JNJ in almost every time frame... could this be a new bottom?
JNJ | I Love It Here | LONGJohnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson BuyHere is my view on JNJ; it is at a support level in a very long uptrend; There is a potential of 15% appreciation if taking profit before the resistance level on cash equity without using leverage.
If using leverage, I'd risk 5% from my trading capital and put a SL below the support area, the Reward to risk will be around 6 to 1 or 30%.
Johnson & Johnson (JNJ) | Inside an Optimal Buying Zone!Hi,
The market has made some pretty good moves up and the current slight correction is bringing prices back to technically good levels and Johnson & Johnson is one of them.
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer goods.
Technically, it has been quite difficult to get it (when there has been such a clear and strong trend, you don't have to be smart to understand that the fundamentals are fine with JNJ), because there have not been such sharp reversals, from which to find a support level and etc, but as you can see from the picture, it has not been impossible. Namely, the price of JNJ has respected a trendline for almost 10 years.
The trend line is drawn from the closing prices (you can do it easily on the line chart) to eliminate the noise and the wicks that the various waves of panic have brought. JNJ has always been bought up very quickly and the growth has been steady.
Also, the price has respected the 50-month moving average (50EMA) almost flawlessly, and at the moment the trend line and the EMA50 form a single punch and are together in one price zone.
Technical criteria for a significant level of support:
1. Trendline, clearly proven in the long term.
2. The Monthly EMA50 has held nicely.
3. The resistance level that worked for three years in 2017-2020, around $150, will start working as a support level.
4. Short-term channel projection
5. Short-term equal waves from the top: AB=CD
The optimal entry point should stay between $147-$160.
Good luck!
NYSE:JNJ 13th FEBRUARY 2023The trendline is the most common part of technical analysis in forex trading. But when compared to support and resistance, trendlines are less commonly used. The trendline should be more significant due to the number of touches.
Trendlines are very suitable in combination with several technical indicators, one of which is the Money Flow Index ( MFI ).
MFI is an indicator used to measure money inflows and outflows from local and foreign investors in the stock. Since MFI measures money inflows and outflows, it also involves volume in its indicator.
In other words, MFI also measures market interest in a stock (inflows and outflows are closely related to market interest). That's why MFI also includes volume in its indicator.
How to read the MFI indicator is very easy, almost the same as how to read other indicators, such as the relative strength index, stochastic, and others.
MFI has 2 main boundary lines, the overbought and oversold lines. The overbought line is at 80 and above. The oversold line is 20 and below (note the arrow above). This means that if the MFI indicator is at 80 and above, there has been too much money inflow from investors, which causes the stock price to rise, thus causing overbought.
Meanwhile, if the MFI indicator is at 20 and below, there is too much money outflow from investors, which causes the stock price to fall, causing oversold.
What to expect this coming week: Dollar, S&P 500, Gold, META, CLThis is my expectations in the market, what I'm looking at in my watchlist and the economic data
Johnson & Johnson – Head and ShouldersBoth macro (lawsuit, bankrupcy denied to mitigate fines) and technical points to downside in the short term. Here we see a head and soulders formation, with downside target coinciding with monthly 100 SME. Strong support for long term hold.
$JNJ with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $JNJ after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 50%.
$JNJ: Heartline Rejection Targeting 38.2%-61.8% RetraceJohnson & Johnson has rejected the Heartline of the Equidistant Channel while showing Bearish Divergence on the MACD and RSI and as a result i now think it will be heading for a minimum .382-.618 Retrace and i will be playing it via monthly put options.
rttghtertrgretgyrr55rythrthtrhthrrthrthyyr56y56y5y445y5y45y5454y54yy455y45yy5y5y5y45y5yrthrththrthrtrhrthrth
JNJ Rising Wedge Break + Fib LevelHas broken to the downside, the initial moves retracement looks to be done, setting up for another leg down.
JNJ A PEDIDO DE MIGUELwww.economiaendigerido.com.ar
Análisis de JNJ para Miguel. Pedime activos y los vemos.
Definitely don’t want to invest in..Sorry but a company responsible for the opioid pandemic is probably not on my investment list for sure pretty much a legal drug lord in my opinion how do not have records of how much drugs you make sounds a little fishy
Johnson & JohnsonFalling Wedge Pattern Breakout and Retest
Formation of HH and HL
Support from 61% fib retracement
Entry after formation of HL (176.34)
Trade with specified Stop Loss
TP levels are specified
Ride the trend with trailing stop Loss
Manage your risk accordingly
JNJ Buy Long on StrengthJNJ fundamentally is a cross between Big Pharm and Consumer Staples
Recent Earnings were solid not spectacular but the latter is not expected here.
Technically, JNJ climbs higher without much volatility, At the moment it
is rising in a small cycle within the supertrend. Strength is increasing
and some bearish momentum is exhausting. This is a low-beta stock and it
does not react much to the larger broad market. I see this as a good time
for a LEAP option for early 2024 at a strike 15% above the current price.
Going Long in Johnson & Johnson - JNJHello Traders,
Johnson & Johnson JNJ - NYSE
Buy / Long Trade Plan.
Entry Level @ Above 23.6% FIB level / 4 Hour resistance level with bullish candle @ 178.00
Take Profit 1 @ Below 4 Hour resistance level 180.60
Take Profit 2 @ Below Daily resistance / FIB 0.0% level 182.96
Stop Loss @ Below Daily Support Level @ 176.17
Lot Size :
Portfolio Size 10000$
Risk to Reward 1 : 1
Lot size 216 units @ 5% Risk
TP 1 = Total PIPS in gain = 260 Profit 1.61 %
TP 2 = Total PIPS in gain = 496 Profit 2.92 %
Total PIPS in Stoploss = 183 Loss 0.88 %
Regards.
JOHNSON & JOHNSON Can reach $190 by FebruaryJohnson & Johnson (JNJ) has been trading within a long-term Bullish Megaphone pattern since the January 26 2021 High. The pattern has been having very structured Higher Highs and Higher Lows.
At the moment the stock is on a bullish leg, after rebounding exactly on the 1D MA50 (blue trend-line) on November 11 and is also above the 1D MA200 (orange trend-line). The 1W MACD is on a Bullish Cross and the 1W RSI rebounded off a Lower Lows (Double) Bottom formation. The exact same sequence was last seem early this year on January. After one last pull-back, the stock then rallied to the top (Higher Highs trend-line) of the Bullish Megaphone.
The Higher Highs seem to be following the 1.236 - 1.5 - 1.786 Fibonacci sequence and so do the Lows (0.236 - 0.5 - 0.786). The 1.786 Fib extension is a little over $190.00 and that is our current long target on JNJ.
-------------------------------------------------------------------------------
** Please LIKE 👍, SUBSCRIBE ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support me, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
You may also TELL ME 🙋♀️🙋♂️ in the comments section which symbol you want me to analyze next and on which time-frame. The one with the most posts will be published tomorrow! 👏🎁
-------------------------------------------------------------------------------
👇 👇 👇 👇 👇 👇
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
$JNJ with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $JNJ after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 33.33%.
